In addition, SB431542, a TGF-β1 receptor inhibitor, reversed the TAM-type promotion effects, indicating that the GRP78-overexpressing gastric cancer cells promoted TAM-type macrophages through the TGF-β1 signaling pathway (Figure 4B–D). The gene discussed is TGFB1; the disease is gastric cancer.